Please note: ecancermedicalscience’s submission criteria have been refined to only accept articles which feature at least one author from a Lower and Middle Income Country (LMIC), or which have a significant impact on under-resourced settings. This decision has been taken in order to focus the journal's resources on proactively supporting authors from LMICs, where the majority of new cancer cases will occur over the next two decades, and the global collaborations that are vital to the development of key skills in this area.
Publishing with ecancermedicalscience is free for those who do not have funding
ecancermedicalscience publishes using a "pay what you can afford" model. If you do not have access to funding, you do not have to pay an article processing charge. We offer an unbiased service to the oncology community to make the latest research available to all. We are fully compliant with the open access policies of funding agencies worldwide.
The electronic submission process is quick and easy and the average time from submission to acceptance is under 90 days. We have a large group of expert peer reviewers and editors working with the journal, as well as a highly esteemed Editorial Board.
The journal accepts Spanish submissions. They go through the usual peer review process and, if accepted, are translated into English and published for free, as well as appearing in Spanish.
As an online-only journal, ecancermedicalscience gives authors the opportunity to publish large datasets, large numbers of illustrations and videos and the opportunity to include all relevant links (for example, to sequence and other databases, and to other papers), that improve the readers experience. We also offer a free language editing service.
Once published, your article will immediately be available to the large number of international visitors to the ecancer website (over 50,000 unique visitors per month from 196 countries) and the full text of each article will be permanently archived within ecancermedicalscience. Additionally, ecancermedicalscience is included in the Web of Science (via the Emerging Sources Citation Index), Dictionary of Open Access Journals (DOAJ) and SHERPARoMEO.
Articles are indexed in PubMed, PubMed Central, Web of Science, Embase, Scopus, EBSCO and Google Scholar, so your article will be highly accessible to other researchers in the field. The full text versions of ecancermedicalscience articles are viewed over 60,000 times a month in PubMed Central. Authors retain the copyright of their articles so are free to distribute them as they wish.
ecancermedicalscience features article level metrics, which give authors the ability to discover the wider impact of individual articles in a way that has not previously been possible.
These include the Altmetric badge, which allows authors to track the impact of their articles via social media, citations, inclusion in policy documents, mainstream media coverage and many other online engagements.
ecancer also uses the PLoS ALM open source application to display article views on ecancer.org and PubMed.
See altmetrics.org, What can article-level metrics do for you? and Alternative metrics for measuring the quality of articles and journals for more information on alternative metrics.
Submission is fast and easy. Click here to submit your article now.
Citations to ecancermedicalscience articles have been rapidly increasing year on year, with a current H-index of 30.
Watch this video for authors' personal experiences of publishing with ecancermedicalscience.
“We are highly grateful and appreciate the ecancermedicalscience journal team for its quick response and fast review process. It was a seamless publication process and a wonderful experience.”
--Mukhtar Ahmad Dar, National Institute of Pharmaceutical Education and Research (NIPER), Bihar, India
“We are truly inspired by the work that you do - I also feel very passionate about the need to educate and empower physicians in these lower resourced settings and also to shine a light on the seriousness of disease here, so that we can work together to improve outcomes for patients.”
--Maria Gosein, University of the West Indies, Trinidad
“I want to deliver my heartfelt gratitude for your journal, the level of cooperation, professionalism and help is something I have never come across while working with any other journal.”
-- Mona Hassan, American University of Beirut Medical Center, Lebanon
“Thank you for your support, it was amazing working with you through this whole process. I also appreciate the support of ecancer charity for covering the cost of the publication.”
-- Nuhu Tumba, Bingham University Teaching Hospital, Nigeria
“I am so happy and proud to publish my scientific work in ecancer, my favorite journal.”
--Enas Abou Bakr Elkhouly, Menoufia University, Egypt.
“I must admit that ecancer is the most efficient journal that I have ever worked with”
--Prof D Cristina Stefan, SingHealth Duke-NUS Global Health Institute (SDGHI), Duke-NUS Medical School, Singapore
“I am quite acquainted with ecancermedicalscience since my medical school days as it is one journal that we read because it offers the full text freely to its readers. I chose to submit in this journal because it offers wide readership, good indexing, and it also offers authors like me who come from the low and middle income countries a chance for publication with waived APCs.”
--Frederic Ting, University of the Philippines – Philippine General Hospital, Manila, The Philippines
“We have also had the good fortune of publishing with your journal a few weeks back. It has been a great experience both times”
--Danielle Benedict Sacdalan, College of Medicine, University of the Philippines, Manila, The Philippines
“I have published several papers in national and international journals. The experience of submitting, peer-review in ecancer, and the friendly responses are all outstanding.”
--Saleh Alessy, Cancer Epidemiology, Population and Global Health, King's College London, UK
"I would like to thank the entire editorial group for steering the publication and adding components that increased its reading value. The article went through several rounds of suggestions and helpful inputs for which I will always be thankful. It was a privilege submitting to ecancermedicalscience and I thank you for your inputs/ help/ support."
--Digpal Dharkar, Indore Cancer Foundation Charitable Trust, India
"Thank you again for the effort placed into the reading, editing, and refining the manuscript for publication. We truly appreciate ecancer's model that allows all authors to publish regardless of their financial abilities. "
--Qian Qin, Houston Methodist Cancer Center, Texas, USA
"ecancermedicalscience is dynamic, progressive, far-reaching and with stringent and uncompromising selection criteria, and a truly professional editorial team. It’s been fantastic working with you and your guidance and recommendations improved the manuscript at every stage. It is a great privilege to have an article in such a prestigious journal and to be able to contribute to such laudable activities."
--Keith McCormack, Head of Research, McCormack Ltd, London, United Kingdom
"We are indeed very grateful for the support (including financial) that has made this publication possible."
--Gek Phin Chua, National Cancer Centre Singapore
"Editorial assistance such as you provide is hard to match"
--Prof Franco Muggia, Perlmutter Cancer Center at NYU Langone Medical Center, USA
"I had a great time and a delightful experience with ecancer at the Congress in Salvador, Brazil. All the ecancer team was warm and kind with me and also gave me time and flexible schedule to arrange the interview. I truly believe that it was a great opportunity to expose my ideas and thoughts, since ecancer has an international audience. I look forward to publishing another paper in the journal and will definitely suggest for other researchers to do so."
--Dr Daniel Cesar, Instituto Nacional de Câncer, Rio de Janeiro, Brazil
"I would like to thank the entire committee of this esteemed journal for their enormous support towards authors for their high quality publication."
--Prof Sandhya Tamgadge, Dr D Y Patil Dental College & Hospital, India
"I am impressed with the speed, fees and indexing of the journal as well as with the quality of the articles."
--Dr Alok Mishra, National Cancer Institute, Bethesda, USA
"As an organisation that both funds and conducts research it is vitally important that we know the impact that our research is having. With the article level metrics feature on the ecancer website it is easy for us to track just how many people are accessing our publications so that we know our work is having a continuing benefit long after the research has been published."
--Dr Ian Lewis, Director of Research and Policy, Tenovus Cancer Care, Wales, UK
"Thank you for working with us on this special issue. Great job by ecancer."
--Prof Folakemi Odedina, University of Florida, USA
“I hereby convey my heartfelt thanks to you for the valuable help extended to me in preparing manuscript. It was so kind of you that you guided me in every step whenever required.”
-- Dr Neha Modak, Dr D Y Patil Dental College & Hospital, India
“Thanks again for the rapid and expert publication process.”
-- Amany Abou-Bakr, National Cancer Institute, Cairo University, Egypt
"The innovative ecancer platform gives our work a lot of visibility, with videos and a presence in major conferences."
-- Ana Catarina Pinto, Breast Cancer Research Fellow & PhD Student, Br.E.A.S.T. Data Centre, Jules Bordet Institute, Belgium
"The submission process was the easiest I ever used, for real - congratulations."
--Dr Felipe Ades, Jules Bordet Institute, Belgium
“I selected ecancermedicalscience to submit my article based on the fact that it is both open access and free to publish, as well as the quality of the founding members and current editorial team...I commend ecancermedicalscience for what it is doing as a trendsetter in the scientific publishing community.”
--Patrick Logan, The Henry C. Witelson Ocular Pathology Laboratory, McGill University, Montreal, Canada
"The free access to the whole world is just a priceless gift from the ecancer team.”
-- Dr Praveen Rathod, Kidwai Memorial Institute of Oncology, India